#SanjanaRanganathan, rising MS4, reports no diff in overall survival with combo immuno/targeted therapy or immuno alone over targeted alone for mpRCC. #CarlosRiveros, incoming ⁦Houston Methodist Urology and Residency Program⁩ R1 under mentorship of ⁦Raj Satkunasivam⁩ #AUA23

⁦Emily Huang⁩ shares a systematic review and metaanalysis of RCTs on adjuvant therapy for RCC. ⁦Houston Methodist Urology and Residency Program⁩ ⁦Raj Satkunasivam⁩ #SanjanaR ⁦Christopher Wallis (he/him/his)⁩ #CarlosRiveros #AUA23

❤️our collaboration between teaching faculty Houston Methodist Urology and Residency Program Houston Methodist MD and Texas A&M School of Engineering Medicine! Taught surgical sim workshop alongside Raj Satkunasivam about functional #urology and Onc w hands on lab on Intuitive #SP and BPH therapies #Rezum #Greenlight simulators, iTind etc

Houston Methodist Urology and Residency Program is partnering with BCM Department of Urology, University of Texas Houston Urology, UTMBUrology & BSW Urology Residency for the 1st Annual Collaborative Urologic Research Symposium (CUReS) on August 2nd at Houston Methodist! REGISTER HERE: learn.houstonmethodist.org/CURES-2023#gro… Texas A&M Medicine Houston Methodist Residency & Fellowship Programs Texas Medical Center

All Houston urology programs together for a day to share ongoing research. Rose Khavari MD kicks off the 2nd annual #CUReS. Houston Methodist Urology and Residency Program BCM Department of Urology University of Texas Houston Urology UTMBUrology Amer. Urol. Assn. Jennifer Taylor, MD Raj Satkunasivam Ricardo R Gonzalez MD Chester Koh, MD, MBA Dharam Kaushik #HoustonCollaboration

The RAD VACCINE MIBC trial is a fresh look at combining neoadjuvant sasanlimab with SBRT as an in situ vaccine in cisplatin-ineligible muscle-invasive #bladdercancer. Raj Satkunasivam of Houston Methodist Urology and Residency Program explains its purpose in more detail buff.ly/45jMb4z

Findings of this study suggest that patients treated by female surgeons have a lower risk-adjusted likelihood of adverse postoperative outcomes at 90 days and 1 year following surgery. ja.ma/3Z0buH4 Christopher Wallis (he/him/his) Angela Jerath MD, MSc Raj Satkunasivam

This week on BT URO: DrBagrodia and Dharam Kaushik discuss how yoga can prevent burnout and encourage compassion. #UroSoMe Houston Methodist Urology and Residency Program Phillip Pierorazio Piyush Kumar Agarwal Rose Khavari MD Raj Satkunasivam Kathleen Kobashi UCSD Urology Manoj Monga Angie Smith cms.megaphone.fm/channel/BTL216…

Are you interested in our Robotic/Oncology Fellowship? 🤔 Then you're in luck because we are now taking applications for our 2025-2026 fellowship cycle!🙌 Scan the QR code for more information and email [email protected] to apply. #Fellowship #LeadingMedicine

GU Onc friends: ⚡️❓Do you do radical prostatectomies❓🙋🏻‍♂️ ✨✨Please help answer a *10 minute* survey about referral patterns for post prostatectomy incontinence! ✨✨ docs.google.com/forms/d/e/1FAI… Let’s learn from what the experts are doing  👀🌟 Society of Urologic Oncology Society of Academic Urologists @amerurological

Our latest is out in The BMJ looking at the effect of patient-surgeon gender concordance and outcomes bmj.com/content/383/bm… The astute may notice that the conclusions seem to differ from some of our prior work. I want to take you beyond the headlines into the data...

Most viewed this week across the JAMA Network? From JAMA Surgery JAMA Surgery Surgeon Sex and Health Care Costs for Patients Undergoing Common Surgical Procedures Christopher Wallis (he/him/his) Raj Satkunasivam & colleagues jamanetwork.com/journals/jamas…

Superstition in Surgery - Should we operate on Friday the 13th? journals.lww.com/aosopen/fullte… Sanjana Ranganathan Christopher Wallis (he/him/his)

Over ~20 yrs, #ShelbyWebsterTestisCAConsortium has grown into an internat’l exchange b/t brilliant minds in testis CA care. Looking forward to hosting y’all Houston Methodist MD in ‘25! Sia Daneshmand, M.D. #ChrisPorter Craig Nichols Anne Schuckman USC Urology Raj Satkunasivam Dharam Kaushik

A phase II clinical trial of neoadjuvant sasanlimab and SBRT as an in situ vaccine for cisplatin-ineligible muscle invasive #BladderCancer. Presented by Raj Satkunasivam Houston Methodist Urology and Residency Program. #EAU24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/4apa3Xs European Association of Urology (EAU)

Our latest in Annals of Surgery We conducted a meta-analysis including 15 studies with 5 million pts, and found pts treated by female surgeons experienced better outcomes compared with pts treated by male surgeons. Christopher Wallis (he/him/his) Angela Jerath MD, MSc Raj Satkunasivam journals.lww.com/annalsofsurger…

We are back with our 4th Annual Collaborative Urologic Research Symposium (CUReS) in partnership w/ BCM Department of Urology, University of Texas Houston Urology, Texas A&M Medicine & UTMBUrology on August 7th at the HMH Research Institute Save the date & spread the word! 🪩🤗 Register Here: learn.houstonmethodist.org/cures-2024#gro…

🥳 Houston just had its 1st #VAPOR2 procedure! Thanks to Raj Satkunasivam & team at Houston Houston Methodist for working to #Vanquish #ProstateCancer in a way that is #GentleOnPatients, #ToughOnCancer 💪 💦 More about #CancerAblationByWaterVapor at francismedical.com #FocalTherapy

This week, Raj Satkunasivam Rose Khavari MD Houston Methodist Urology and Residency Program meet with #urology legend Timothy Boone, MD, PhD, DSc (hon) to discuss how humanism and empathy can improve career satisfaction and patient care Kathleen Kobashi Akhil Muthigi, MD Mohit Khera Angie Smith @urodoco #URO185 open.spotify.com/episode/1wYqZl…

It was so fun to present updates on #bladdercancer to Urology residents Houston Methodist on 8/22; thanks Keith Syson Chan Lab Raj Satkunasivam for the invite! Great prep for amazing IBCG meeting! Pavlos Msaouel Ashish M. Kamat, MD, MBBS Omar Alhalabi, MD Eleni Efstathiou Hsieh Lab Fred Hutchinson Cancer Center Dr. Bishoy M. Faltas